SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-024520
Filing Date
2023-07-14
Accepted
2023-07-13 18:56:35
Documents
4
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 628350
2 formdef14a_001.jpg GRAPHIC 11692
3 proxy_001.jpg GRAPHIC 297000
4 proxy_002.jpg GRAPHIC 427769
  Complete submission text file 0001493152-23-024520.txt   1643650
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 231087686
SIC: 2834 Pharmaceutical Preparations